发明名称 |
COMPOSITION OF SOLIFENACIN OR SALT THEREOF FOR USE IN SOLID FORMULATION |
摘要 |
<p>A solid pharmaceutical preparation of solifenacin or a salt thereof, the preparation being stable and inhibited from decomposing with time when supplied to clinical fields. In a pharmaceutical preparation containing solifenacin or a salt thereof, the compound in an amorphous form was reveale d to be causative of cardinal-drug decomposition with time. The composition fo r a solid pharmaceutical preparation of solifenacin or a salt thereof contains solifenacin or its salt each in a crystalline form, and the content of the compound in an amorphous form in the composition is within the range which exerts no influence on product stability. Also provided are: a process for producing the composition; and a medicinal composition for solid pharmaceutical preparations which contains solifenacin and an amorphization inhibitor.</p> |
申请公布号 |
CA2561167(A1) |
申请公布日期 |
2005.10.06 |
申请号 |
CA20052561167 |
申请日期 |
2005.03.24 |
申请人 |
ASTELLAS PHARMA INC. |
发明人 |
MASAKI, KATSUHIRO;SUGIHARA, AKIO;YASUJI, TAKEHIKO;MURAYAMA, DAISUKE |
分类号 |
C07D453/02;A61K9/20;A61K31/439;A61K47/34;A61P1/12;A61P13/02;A61P27/08 |
主分类号 |
C07D453/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|